Search

Your search keyword '"Gori F"' showing total 1,085 results
Start Over Author "Gori F"
1,085 results on '"Gori F"'

1. A Call to Action by the Italian Mesotherapy Society on Scientific Research

Author

Mammucari M, Paolucci T, Russo D, Maggiori E, Di Marzo R, Migliore A, Massafra U, Ronconi G, Ferrara PE, Gori F, Bifarini B, Brauneis S, Vellucci R, Mediati RD, Violo B, Natoli S, Pediliggieri C, Di Campli C, and Collina MC

Subjects
mesotherapy, intradermal therapy, research plan, Therapeutics. Pharmacology, RM1-950
Abstract

Massimo Mammucari,1 Teresa Paolucci,2 Domenico Russo,3 Enrica Maggiori,1 Raffaele Di Marzo,4 Alberto Migliore,5 Umberto Massafra,5 Gianpaolo Ronconi,6 Paola Emilia Ferrara,6 Fabio Gori,7 Barbara Bifarini,7 Stefano Brauneis,8 Renato Vellucci,9 Rocco Domenico Mediati,9 Bartolomeo Violo,10 Silvia Natoli,11 Carmen Pediliggieri,12 Cristiana Di Campli,12 Maria Chiara Collina12 1Primary Care Unit, ASL RM 1, Rome, Italy; 2Unit of Physical Medicine and Rehabilitation, G. D’ Annunzio University of Chieti-Pescara, Department of Oral Medical Science and Biotechnology (DSMOB), Chieti, Italy; 3“San Marco” Hospice and Palliative Care, Latina, Italy; 4Member of the Italian Society of Mesotherapy, Rome, Italy; 5Unit of Rheumatology, San Pietro Fatebenefratelli Hospital, Rome, Italy; 6Physical Medicine and Rehabilitation Unit, IRCCS, Catholic University of Sacred Heart, Rome, Italy; 7Section of Anaesthesia, Intensive Care, and Pain Medicine, University Hospital Santa Maria Della Misericordia, Perugia, Italy; 8Pain Centre “Enzo BorzomatI”, University Hospital of Rome “Policlinico Umberto I”, Rome, Italy; 9Anaesthesiology Department, University Hospital Careggi, Florence, Italy; 10Pain Therapy Unit, S. Spirito Nuovo Regina Margherita Hospital, Rome, Italy; 11Department of Clinical Science and Translational Medicine, Tor Vergata University, Rome, Italy; 12Department of Vascular Surgery, Limb Salvage and Diabetic Foot, IDI-IRCCS, Rome, ItalyCorrespondence: Massimo MammucariPrimary Care Unit, Local Health, ASL RM 1, Rome, 00165, ItalyTel +39-06-61560695 Email massimo.mammucari@libero.itAbstract: Mesotherapy (local intradermal therapy, LIT) is a technique used to slowly spread drugs in tissues underlying the site of injection to prolong the pharmacological effect with respect to intramuscular injection. Recommendations for proper medical use of this technique have been made for pain medicine and rehabilitation, chronic venous disease, sport medicine, musculoskeletal disorders, several dermatological conditions, skin ageing, and immune-prophylaxis. Although mesotherapy is considered a valid technique, unresolved questions remain, which should be answered to standardize methodology and dosing regimen as well as to define the right indications in clinical practice. New randomized controlled trials are needed to test single products (dose, frequency of administration, efficacy and safety). Even infiltration of substances for dermo-cosmetic purposes must be guided by safety and efficacy tests before being proposed by mesotherapy. In this article, we put forth a preclinical and clinical research plan and a health technology assessment as a call to action by doctors, researchers and scientific societies to aid national health authorities in considering mesotherapy for prevention, treatment and rehabilitation paths.Keywords: mesotherapy, intradermal therapy, research plan

Published
2021

7. 1st Roman Young Researchers Meeting Proceedings

Author

Cannuccia, E., Migliaccio, M., Pietrobon, D., Stellato, F., Veneziani, M., Sabbatini, L., Dall'Oglio, G., Pizzo, L., Cavaliere, F., Miriametro, A., Gallerani, S., Santini, P., D'Ammando, F., Vercellone, S., Donnarumma, I., Pacciani, L., Pucella, G., Tavani, M., Vittorini, V., Bulgarelli, A., Chen, A. W., Giuliani, A., Longo, F., Paggi, A., Turriziani, S., Abundo, P., Armisi, L., Gori, F., Rosato, N., Cattani, G., Racioppi, A., and Tarantino, W.

Subjects
Physics - General Physics, Astrophysics - Cosmology and Extragalactic Astrophysics, High Energy Physics - Phenomenology
Abstract

During the last few decades scientists have been able to test the bases of the physics paradigms, where the quantum mechanics has to match the cosmological scales. Between the extremes of this scenario, biological phenomena and their complexity take place, challenging the laws we observe in the atomic and sub-atomic world. In order to explore the details of this world, new huge experimental facilities are under construction. These projects involve people coming from several countries and give physicists the opportunity to work together with chemists, biologists and other scientists. The Roman Young Researchers Meeting is a conference, organised by Ph. D. students and young postdocs connected to the Roman area. It is aimed primarily at graduate students and post-docs, working in physics. The 1st conference has been held on the 21st of July 2009 at the University of Roma Tor Vergata. It was organised in three sessions, devoted to Astrophysics and Cosmology, Soft and Condensed Matter Physics and Theoretical and Particle Physics. In this proceeding we collect the contributions which have been presented and discussed during the meeting, according to the specific topics treated., Comment: Proceedings of the 1st Young Researchers Meeting Rome, July 21st 2009 website: http://ryrm.roma2.infn.it/ryrm/index1.htm high resolution .pdf available at: http://ryrm.roma2.infn.it/ryrm/1st_meeting/database/1stRYRM_Proceedings.pdf

Published
2009

8. Non-quantum entanglement and a complete characterization of pre-Mueller and Mueller matrices in polarization optics

Author

Simon, B. Neethi, Simon, Sudhavathani, Mukunda, N., Gori, F., Santarsiero, Massimo, Borghi, Riccardo, and Simon, R.

Subjects
Quantum Physics
Abstract

The Mueller-Stokes formalism which governs conventional polarization optics is formulated for plane waves, and thus the only qualification one could demand of a $4\times 4$ real matrix $M$ in order that it qualifies to be the Mueller matrix of some physical system is that $M$ should map $\Omega^{({\rm pol})}$, the positive cone of Stokes vectors, into itself. In view of growing current interest in the characterization of partially coherent partially polarized electromagnetic beams, there is need to extend this formalism to such beams wherein the polarization and spatial dependence are generically inseparably intertwined. This inseparability or non-quantum entanglement brings in additional constraints that a pre-Mueller matrix $M$ mapping $\Omega^{({\rm pol})}$ into itself needs to meet in order that it is an acceptable physical Mueller matrix. These additional constraints are motivated and fully characterized., Comment: 16 pages. Talk presented at the Koli Workhsop on `Partial Electromagnetic Coherence and 3D Polarization'

Published
2009

9. Non-quantum entanglement resolves a fundamental issue in Polarization optics

Author

Simon, B. Neethi, Simon, Sudhavathani, Gori, F., Santarsiero, Massimo, Borghi, Riccardo, Mukunda, N., and Simon, R.

Subjects
Quantum Physics
Abstract

The issue raised in this paper is classical in the sense of being ancient: which subset of 4X4 matrices should be accepted as physical Mueller matrices in polarization optics? Non-quantum entanglement between the polarization and spatial degrees of freedom of an electromagnetic beam is shown to provide the physical basis to resolve this issue in a definitive manner., Comment: 4 pages, no figures

Published
2009

10. Understanding complex effects on clinical outcomes and biomarker activities of food supplementation in heavy smokers: an approach using bayesian networks.

Author

Vigna, L., Gori, F., Bamonti, F., Tomaino, L., Zaccagna, C.A., Cighetti, G., Dellanoce, C., and Gregori, D.

Subjects
*BAYESIAN analysis, *MONTE Carlo method, *CARDIOVASCULAR diseases risk factors, *TREATMENT effectiveness, *BIOMARKERS, *BERRIES, *ENRICHED foods
Abstract

BACKGROUND: Antioxidant administration can significantly alleviate smoking-mediated oxidative stress. In our previous research, using a concentrated mixed juice powder led to significant reduction in oxidative status markers and improved lung function among smokers. OBJECTIVE: To compare the effectiveness of different antioxidant formulations of the retail product Juice Plus+® on oxidative status and lung function in healthy smokers via a a Bayesian Network (BN) analysis. METHODS: At baseline and after 3 months' supplementation, pulmonary function, cardiovascular risk factors, and oxidative status were assessed in 101 smokers, randomized into three groups: placebo (P), fruit/vegetable (FV), and fruit/vegetable/berry (FVB) group. BN analysis was performed via Monte Carlo simulations. Statistical significance was assigned as p < 0.05. RESULTS: No significant interaction was observed in P (network score –101.4, p = ns), whereas overall fit significantly improved in both FV (network score –185.7, p = 0.01) and FVB (–293.7, p = 0.003). Moreover, P group's respiratory parameters appeared unrelated to the biochemical structure, whereas those of the FV and, to a greater extent, FVB groups were definitely related to it CONCLUSIONS: BN analysis demonstrated that the FV and FVB formulations contain nutraceutical compounds capable of synergistically acting and improving antioxidant modulation and respiratory function in smoking subjects [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. OC 05.4 Defective Nitric Oxide Production and Increased Reactive Oxygen Species Generation by Platelets from COVID-19 Patients

Author

Petito, E., primary, Guglielmini, G., additional, De Robertis, E., additional, Giglio, E., additional, Becattini, C., additional, Falcinelli, E., additional, Franco, L., additional, Tondi, F., additional, Gori, F., additional, Vaudo, G., additional, Cerotto, V., additional, Paliani, U., additional, and Gresele, P., additional

Published
2023
Full Text
View/download PDF

14. Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials

Author

Ahmadizar F., Luxi N., Raethke M., Schmikli S., Riefolo F., Saraswati P. W., Bucsa C., Osman A., Liddiard M., Maques F. B., Petrelli G., Sonderlichova S., Thurin N. H., Villalobos F., Trifiro G., Sturkenboom M., Moretti U., Bellitto C., Ciccimarra F., Gonella L. A., Arzenton E., Chiamulera C., Lora R., Bellantuono D., Sabaini A., Firenze A., Zodda D., Guidotti F., Zappone M., Alagna B., Cutroneo P. M., Minore C., Costantino C., Vitale F., D'Alessandro G., Morreale I., Marsala L., Farinella D., Bavetta S., Fantini M. P., Reno C., Raschi E., Poluzzi E., Sapigni E., Potenza A. M., Podetti D., Nikitina V., Ricciardelli R., Mogheiseh N., Croce S., Paltrinieri B., Castellani S., Sangiorgi E., Selleri M., Lucchesi S., Catucci G., Savini D., Sacripanti C., Faccioli M., Romio M. S., Rossi L., Radici S., Negri G., Fares L., Ajolfi C., Fadda A., Chiarello A., Pieraccini F., Gavioli B., Palazzi S., Tuccori M., Vannacci A., Bonaiuti R., Ravaldi C., Lombardi N., Crescioli G., Gori F., Tessari R., Zandona E., Zanoni G., Senna G., Crivellaro M. A., Cancian M., Venturini F., Ferri M., Leonardi L., Orzetti S., Caccin E., Baldo P., Capuano A., Rafaniello C., Ferrajolo C., Pagliaro C., Mercaldo M., di Giorgio A., Tari M., Manna S., Farina G., Di Mauro C., De Carlo I., Senesi I., Pileggi C., Palleria C., Gallelli L., De Sarro G., de Sarro C., Verduci C., Papadopoli R., Trabace L., Morgese M., Schiavone S., Tucci P., Bove M., Lapi F., Cricelli C., Racagni G., Tonolo S., Fava G., Giuffrida S., Amato V., Gambera M., Montresor V., Mastropasqua D., Ahmadizar F., Luxi N., Raethke M., Schmikli S., Riefolo F., Saraswati P.W., Bucsa C., Osman A., Liddiard M., Maques F.B., Petrelli G., Sonderlichova S., Thurin N.H., Villalobos F., Trifiro G., Sturkenboom M., Moretti U., Bellitto C., Ciccimarra F., Gonella L.A., Arzenton E., Chiamulera C., Lora R., Bellantuono D., Sabaini A., Firenze A., Zodda D., Guidotti F., Zappone M., Alagna B., Cutroneo P.M., Minore C., Costantino C., Vitale F., D'Alessandro G., Morreale I., Marsala L., Farinella D., Bavetta S., Fantini M.P., Reno C., Raschi E., Poluzzi E., Sapigni E., Potenza A.M., Podetti D., Nikitina V., Ricciardelli R., Mogheiseh N., Croce S., Paltrinieri B., Castellani S., Sangiorgi E., Selleri M., Lucchesi S., Catucci G., Savini D., Sacripanti C., Faccioli M., Romio M.S., Rossi L., Radici S., Negri G., Fares L., Ajolfi C., Fadda A., Chiarello A., Pieraccini F., Gavioli B., Palazzi S., Tuccori M., Vannacci A., Bonaiuti R., Ravaldi C., Lombardi N., Crescioli G., Gori F., Tessari R., Zandona E., Zanoni G., Senna G., Crivellaro M.A., Cancian M., Venturini F., Ferri M., Leonardi L., Orzetti S., Caccin E., Baldo P., Capuano A., Rafaniello C., Ferrajolo C., Pagliaro C., Mercaldo M., di Giorgio A., Tari M., Manna S., Farina G., Di Mauro C., De Carlo I., Senesi I., Pileggi C., Palleria C., Gallelli L., De Sarro G., de Sarro C., Verduci C., Papadopoli R., Trabace L., Morgese M., Schiavone S., Tucci P., Bove M., Lapi F., Cricelli C., Racagni G., Tonolo S., Fava G., Giuffrida S., Amato V., Gambera M., Montresor V., and Mastropasqua D.

Subjects
COVID-19 Vaccines, safety, Surveillance Systems, Pivotal Clinical Trials
Abstract

Background and Objectives: The European Medicine Agency extended the use of Comirnaty, Spikevax, and Nuvaxovid in paediatrics; thus, these vaccines require additional real-world safety evidence. Herein, we aimed to monitor the safety of COVID-19 vaccines through Covid-19 Vaccine Monitor (CVM) and EudraVigilance surveillance systems and the published pivotal clinical trials. Methods: In a prospective cohort of vaccinees aged between 5 and 17 years, we measured the frequency of commonly reported (local/systemic solicited) and serious adverse drug events (ADRs) following the first and second doses of COVID-19 vaccines in Europe using data from the CVM cohort until April 2022. The results of previous pivotal clinical trials and data in the EudraVigilance were also analysed. Results: The CVM study enrolled 658 first-dose vaccinees (children aged 5–11 years; n = 250 and adolescents aged 12–17 years; n = 408). Local/systemic solicited ADRs were common, whereas serious ADRs were uncommon. Among Comirnaty first and second dose recipients, 28.8% and 17.1% of children and 54.2% and 52.2% of adolescents experienced at least one ADR, respectively; injection-site pain (29.2% and 20.7%), fatigue (16.1% and 12.8%), and headache (22.1% and 19.3%) were the most frequent local and systemic ADRs. Results were consistent but slightly lower than in pivotal clinical trials. Reporting rates in Eudravigilance were lower by a factor of 1000. Conclusions: The CVM study showed high frequencies of local solicited reactions after vaccination but lower rates than in pivotal clinical trials. Injection-site pain, fatigue, and headache were the most commonly reported ADRs for clinical trials, but higher than spontaneously reported data.

Published
2023

15. A Minimally Invasive and Highly Effective Extracorporeal CO2Removal Device Combined with a Continuous Renal Replacement Therapy

Author

Zanella, A, Pesenti, A, Busana, M, De Falco, S, Di Girolamo, L, Scotti, E, Protti, I, Colombo, S, Scaravilli, V, Biancolilli, O, Carlin, A, Gori, F, Battistin, M, Dondossola, D, Pirrone, F, Salerno, D, Gatti, S, Grasselli, G, Zanella A., Pesenti A., Busana M., De Falco S., Di Girolamo L., Scotti E., Protti I., Colombo S. M., Scaravilli V., Biancolilli O., Carlin A., Gori F., Battistin M., Dondossola D., Pirrone F., Salerno D., Gatti S., Grasselli G., Zanella, A, Pesenti, A, Busana, M, De Falco, S, Di Girolamo, L, Scotti, E, Protti, I, Colombo, S, Scaravilli, V, Biancolilli, O, Carlin, A, Gori, F, Battistin, M, Dondossola, D, Pirrone, F, Salerno, D, Gatti, S, Grasselli, G, Zanella A., Pesenti A., Busana M., De Falco S., Di Girolamo L., Scotti E., Protti I., Colombo S. M., Scaravilli V., Biancolilli O., Carlin A., Gori F., Battistin M., Dondossola D., Pirrone F., Salerno D., Gatti S., and Grasselli G.

Abstract

OBJECTIVES: Extracorporeal carbon dioxide removal is used to treat patients suffering from acute respiratory failure. However, the procedure is hampered by the high blood flow required to achieve a significant CO2clearance. We aimed to develop an ultralow blood flow device to effectively remove CO2combined with continuous renal replacement therapy (CRRT). DESIGN: Preclinical, proof-of-concept study. SETTING: An extracorporeal circuit where 200 mL/min of blood flowed through a hemofilter connected to a closed-loop dialysate circuit. An ion-exchange resin acidified the dialysate upstream, a membrane lung to increase Pco2and promote CO2removal. PATIENTS: Six, 38.7 ± 2.0-kg female pigs. INTERVENTIONS: Different levels of acidification were tested (from 0 to 5 mEq/min). Two l/hr of postdilution CRRT were performed continuously. The respiratory rate was modified at each step to maintain arterial Pco2at 50 mm Hg. MEASUREMENTS AND MAIN RESULTS: Increasing acidification enhanced CO2removal efficiency of the membrane lung from 30 ± 5 (0 mEq/min) up to 145 ± 8 mL/min (5 mEq/min), with a 483% increase, representing the 73% ± 7% of the total body CO2production. Minute ventilation decreased accordingly from 6.5 ± 0.7 to 1.7 ± 0.5 L/min. No major side effects occurred, except for transient tachycardia episodes. As expected from the alveolar gas equation, the natural lung Pao2dropped at increasing acidification steps, given the high dissociation between the oxygenation and CO2removal capability of the device, thus Pao2decreased. CONCLUSIONS: This new extracorporeal ion-exchange resin-based multiple-organ support device proved extremely high efficiency in CO2removal and continuous renal support in a preclinical setting. Further studies are required before clinical implementation.

Published
2022

16. (718) Multiorgan Donor Bronchoalveolar Lavage Positivity: Incidence, Risk Factors, and Lung Transplant Recipients’ Outcome

Author

Fumagalli, J., primary, Rosso, L., additional, Cattaneo, M., additional, Romeo, G., additional, Scaravilli, V., additional, Righi, I., additional, Damarco, F., additional, Mangioni, D., additional, Gori, F., additional, Bandera, A., additional, Rossetti, V., additional, Morlacchi, L., additional, Nosotti, M., additional, Zanella, A., additional, and Grasselli, G., additional

Published
2023
Full Text
View/download PDF

25. The role of mesotherapy in the management of spinal pain. A randomized controlled study.

Author

Brauneis, S., Araimo, F., Rossi, M., Russo, D., Mammucari, M., Maggiori, E., di Marzo, R., Vellucci, R., Gori, F., Bifarini, B., Chinè, E., Carpenedo, R., Paolucci, T., Giorgio, C., Ritarossi, F., Calò, A., Luongo, L., and Natoli, S.

Subjects
MESOTHERAPY, RANDOMIZED controlled trials, CLINICAL trials, DRUGS, PROPOFOL
Abstract

Background. Mesotherapy is a technique through which active ingredients are administered into the thickness of the skin in order to increase the local analgesic effect. Methods. 141 patients with spinal pain not responding to systemic therapy with NSAIDs were randomized to receive one or more intracutaneous drugs on a weekly basis. Results. All patients achieved a pain reduction of at least 50% compared to baseline, and all tolerated the therapy without having to resort to systemic drug dose increases. Conclusions. The data from our study show that the active ingredients infiltrated into the skin induce a mesodermal modulation between the infiltrated liquid and the cutaneous nervous and cellular structures from which the typical drug-saving effect of mesotherapy arises. Although further studies are needed to establish how to integrate mesotherapy in various clinical settings, it appears to be a useful technique available to the practicing physician. This research is also useful in guiding future clinical research. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

27. Lung Biomolecular Profile and Function of Grafts from Donors after Cardiocirculatory Death with Prolonged Donor Warm Ischemia Time

Author

Gori, F., Fumagalli, J., Lonati, C., Carlin, A., Leonardi, P., Biancolilli, O., Rossetti, A., Righi, I., Tosi, D., Palleschi, A., Rosso, L., Morlacchi, L.C., Blasi, F., Vivona, L., Florio, G., Scaravilli, V., Valenza, F., Zanella, A., and Grasselli, G.

Subjects
inflammasome, Settore MED/10 - Malattie dell'Apparato Respiratorio, Settore MED/21 - Chirurgia Toracica, lung transplantation, Settore MED/41 - Anestesiologia, ex vivo lung perfusion, coagulation, glycocalyx
Abstract

The acceptable duration of donor warm ischemia time (DWIT) after cardiocirculatory death (DCD) is still debated. We analyzed the biomolecular profile and function during ex vivo lung perfusion (EVLP) of DCD lungs and their correlation with lung transplantation (LuTx) outcomes. Donor data, procurement times, recipient outcomes, and graft function up to 1 year after LuTx were collected. During EVLP, the parameters of graft function and metabolism, perfusate samples to quantify inflammation, glycocalyx breakdown products, coagulation, and endothelial activation markers were obtained. Data were compared to a cohort of extended-criteria donors after brain death (EC-DBD). Eight DBD and seven DCD grafts transplanted after EVLP were analyzed. DCD's DWIT was 201 [188;247] minutes. Donors differed only regarding the duration of mechanical ventilation that was longer in the EC-DBD group. No difference was observed in lung graft function during EVLP. At reperfusion, "wash-out" of inflammatory cells and microthrombi was predominant in DCD grafts. Perfusate biomolecular profile demonstrated marked endothelial activation, characterized by the presence of inflammatory mediators and glycocalyx breakdown products both in DCD and EC-DBD grafts. Early graft function after LuTx was similar between DCD and EC-DBD. DCD lungs exposed to prolonged DWIT represent a potential resource for donation if properly preserved and evaluated.

Published
2022

28. NRRP—Italy’s Strategic Reform and Investment Programme: Sustaining an Ecological Transition

Author

F. Cerniglia, F. Saraceno, Barbieri, G., Cerniglia, Floriana Margherita, Gori, F., Lattarulo, P., F. Cerniglia (ORCID:0000-0001-9972-716X), F. Cerniglia, F. Saraceno, Barbieri, G., Cerniglia, Floriana Margherita, Gori, F., Lattarulo, P., and F. Cerniglia (ORCID:0000-0001-9972-716X)

Abstract

In Chapter 4, G. Barbieri, F. Cerniglia, G. F. Gori, and P. Lattarulo provide a general overview of the Italian National Recovery and Resilience Plan (NRRP) with a focus on the investment needs to ensure an ecological transition. The NRRP contains six missions, of which Mission 2 is specifically dedicated to the ecological transition (approximately 59.5 billion euros); however further resources for the transition are also available in other Missions under climate objectives. In total, the available resources are around 71.7 billion euros. This means that out of the total funding allocated to the NRRP (191 billion euros), 37.5% is dedicated to green investment, which is slightly above the minimum threshold set by the EU. In absolute terms, because of the size of the Italian NRRP, this is by far the most significant investment out of all the EU countries. The NRRP is a huge gamble for the future of Italy due to the sheer number of resources involved, the deep structural lags that must be overcome, and the major political consensus needed on the overall objectives and/or missions.

Published
2022

30. A class of vectorial pseudo-Schell model sources with structured coherence and polarization

Author

Martinez-Herrero R., Piquero G., Santarsiero M., Gori F., Gonzalez de Sande J. C., Martinez-Herrero, R., Piquero, G., Santarsiero, M., Gori, F., and Gonzalez de Sande, J. C.

Subjects
Degree of coherence, Polarization, Structured light, Electrical and Electronic Engineering, Propagation, Coherence, Atomic and Molecular Physics, and Optics, Óptica, Electronic, Optical and Magnetic Materials
Abstract

Scalar pseudo-Schell model sources present a degree of coherence depending only on the difference between the radial coordinates of the two considered points. Here we study a class of sources of this kind, but endowed with a vectorial nature. Such sources, as well as the beams they radiate, present structured coherence and polarization features. It is shown that the polarization pattern and the degree of polarization are not uniform across the beam section but remain invariant upon paraxial propagation. Different characteristics of the source and the radiated beam can be obtained by changing the source parameters. Some synthesis procedures are also proposed.

Published
2022

33. On z-coherence in self-focusing

Author

Gori, F., primary, Martínez-Herrero, R., additional, Piquero, G., additional, de Sande, J. C. G., additional, Korotkova, O., additional, and Santarsiero, M., additional

Published
2022
Full Text
View/download PDF

34. Intradermal therapy (mesotherapy): the lower the better

Author

Bifarini, B, Gori, F, Russo, D, Mammucari, M, Maggiori, E, Di Marzo, R, Migliore, A, Massafra, U, Ronconi, G, Ferrara, Pe, Paolucci, T, Vellucci, R, Mediati, D, Violo, B, Natoli, S, and Brauneis, S

Subjects
cervicobrachial pain, Injections, Intradermal, Settore MED/41, Mesotherapy, recommendations, drug dose, Humans, Prospective Studies, Chronic Pain, intradermal therapy, Retrospective Studies
Abstract

Intradermal therapy (mesotherapy) is a technique used to inject drugs into the surface layer of the skin. The intradermal micro deposit allows to modulate the kinetics of drugs, slowing down its absorption and prolonging the local mechanism of action. This technique is applied in the treatment of some forms of localized pain when a systemic drug-saving effect is useful, when it is necessary to synergize with other pharmacological or non-pharmacological thera-pies, when other therapies have failed or cannot be used.The purpose of our study was to evaluate the effect of a mixture with respect to its lower concentration. We also wanted to evaluate the number of sessions needed to reach the therapeutic goal (50% reduction in pain from baseline) in patients with acute or chronic neck pain.We analyzed retrospectively data from 62 patients with cervicobrachial pain treated with intradermal drugs. Group A received a mixture of drugs; group B received half the dose of drugs.Patients who received a lower concentration of drugs achieved similar results to those who received a higher dose. The therapeutic goal was achieved on average with 3.5 + 1.7 sessions on a weekly basis (min 1; max 9). Subjects in group A required 4+1.7 treatments (min 1; max 9), while subjects in group B required 3+1.5 treatments (min 1; max 7).Our study confirms that even a lower dose of drugs can induce a clinically useful result. This study confirms that the useful effect of mesotherapy is only partly due to the pharmacological action. Further randomized prospective studies are needed to standardize the technique in the various pain syndromes, but it is recommended to follow the guidelines of the Italian Society of Mesotherapy to ensure patients receive appropriate treatment.

Published
2022

36. Further results on the mean mass transfer and fluid flow in a turbulent round jet

Author

Angelino, M, Di Venuta, I, Boghi, A, Petracci, I, and Gori, F

Subjects
Settore ING-IND/10, Turbulent round jets, Turbulent Prandtl/Schmidt number, General Chemical Engineering, Potential Core Region (PCR), Mean mass transfer/passive scalar spreading, Condensed Matter Physics, Numerical Large Eddy Simulation (LES), Atomic and Molecular Physics, and Optics, Undisturbed Region of Flow (URF)
Published
2023

41. Exposure to Angiostrongylus vasorum in areas enzootic for VBDs

Author

Morelli, S, Gori, F, Colombo, M, A DI CESARE, Simonato, G, Veronesi, F, Russi, I, and Schnyder, M

Subjects
Angiostrongylus vasorum, Antigen, Antibodies, Vector-borne diseases, Angiostrongylus vasorum, Antigen, Vector-borne diseases, Antibodies
Published
2021

Catalog

Books, media, physical & digital resources
See catalog results